Genetic alterations in MED12 promote castration-resistant prostate cancer through modulation of GLI3 signaling
Schematic diagram of working model. In the absence of androgen, the SHH signaling pathway is turned on leading to an upregulation of the downstream effector GLI3. In the presence of wildtype MED12 (left), a constraint is placed on GLI3 signaling thereby leading to regulated GLI3 target gene expression and a subsequent block to progression towards CRPC. When MED12 is either downregulated or mutated (right), the constraint on GLI3 is lifted thereby leading to hyperactivated GLI3 target gene expression and subsequent progression to CRPC.
Publication
Genetic alterations in MED12 promote castration-resistant prostate cancer through modulation of GLI3 signaling. (2023) Thu Minh Duong, et al. Mol Biol Res Commun. 2023;12(2):63-70. Figure: F5.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | GLS | GLS | ncbigene_symbol | GLS | 2744 |
| Homo sapiens | Primates | GLS | GLS | ncbigene_synonym | GLS2 | 27165 |
| Homo sapiens | Primates | GLI3 | GLI3 | ncbigene_symbol | GLI3 | 2737 |
| Homo sapiens | Primates | por | POR | ncbigene_symbol | POR | 5447 |
| Homo sapiens | Primates | por | POR | ncbigene_synonym | VDAC2 | 7417 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|